BACKGROUND: Norepinephrine (NE) plays a central role in post-traumatic stress disorder (PTSD). Dopamine β-hydroxylase (DβH) converts dopamine (DA) to NE and its activity varies widely across individuals. Mustapic et al. (2007) reported a PTSD-associated deficit in serum DβH activity in a genotype-controlled analysis of combat veterans. We tested whether such a deficit would occur in a sample of civilians. METHODS: The severity of current adult PTSD symptoms and current DSM-IV diagnosis of PTSD were determined by the PTSD Symptom Scale (PSS). Adulthood trauma exposure was assessed using the Traumatic Experience Inventory (TEI). Serum DβH activity (sDβH) was assayed by HPLC with electrochemical detection and genotypes were determined using the Taqman® platform. RESULTS: Two hundred and twenty seven African American (AA) subjects were enrolled in this study, with a mean age (±SD) of 42.9 (±12.9) years. We found a strong association between rs1611115 genotype and sDβH (p<0.0001). After controlling for adulthood trauma exposure, there were no significant differences of sDβH between subjects who met a PTSD diagnosis and those who did not (p>0.05) in any genotype group. No significant correlations were found between sDβH and PTSD severity, but sDβH significantly associated with the status of comorbid depression based on the cutoff of HAMD (p=0.014) in subjects with PTSD. CONCLUSIONS: We have replicated in this sample the prior finding that DBH rs1611115 genotype strongly associates with sDβH. No associations between sDβH and PTSD diagnosis or symptom severity were found in this civilian sample.
BACKGROUND:Norepinephrine (NE) plays a central role in post-traumatic stress disorder (PTSD). Dopamine β-hydroxylase (DβH) converts dopamine (DA) to NE and its activity varies widely across individuals. Mustapic et al. (2007) reported a PTSD-associated deficit in serum DβH activity in a genotype-controlled analysis of combat veterans. We tested whether such a deficit would occur in a sample of civilians. METHODS: The severity of current adult PTSD symptoms and current DSM-IV diagnosis of PTSD were determined by the PTSD Symptom Scale (PSS). Adulthood trauma exposure was assessed using the Traumatic Experience Inventory (TEI). Serum DβH activity (sDβH) was assayed by HPLC with electrochemical detection and genotypes were determined using the Taqman® platform. RESULTS: Two hundred and twenty seven African American (AA) subjects were enrolled in this study, with a mean age (±SD) of 42.9 (±12.9) years. We found a strong association between rs1611115 genotype and sDβH (p<0.0001). After controlling for adulthood trauma exposure, there were no significant differences of sDβH between subjects who met a PTSD diagnosis and those who did not (p>0.05) in any genotype group. No significant correlations were found between sDβH and PTSD severity, but sDβH significantly associated with the status of comorbid depression based on the cutoff of HAMD (p=0.014) in subjects with PTSD. CONCLUSIONS: We have replicated in this sample the prior finding that DBHrs1611115 genotype strongly associates with sDβH. No associations between sDβH and PTSD diagnosis or symptom severity were found in this civilian sample.
Authors: Michael D Köhnke; Cyrus P Zabetian; George M Anderson; Werner Kolb; Ines Gaertner; Gerhard Buchkremer; Reinhard Vonthein; Sandra Schick; Ulrich Lutz; Annette M Köhnke; Joseph F Cubells Journal: Biol Psychiatry Date: 2002-12-15 Impact factor: 13.382
Authors: Joseph F Cubells; Lawrence H Price; Barnett S Meyers; George M Anderson; Cyrus P Zabetian; George S Alexopoulos; J Craig Nelson; Gerard Sanacora; Paul Kirwin; Linda Carpenter; Robert T Malison; Joel Gelernter Journal: Biol Psychiatry Date: 2002-03-01 Impact factor: 13.382
Authors: T D Geracioti; D G Baker; N N Ekhator; S A West; K K Hill; A B Bruce; D Schmidt; B Rounds-Kugler; R Yehuda; P E Keck; J W Kasckow Journal: Am J Psychiatry Date: 2001-08 Impact factor: 18.112
Authors: C P Zabetian; G M Anderson; S G Buxbaum; R C Elston; H Ichinose; T Nagatsu; K S Kim; C H Kim; R T Malison; J Gelernter; J F Cubells Journal: Am J Hum Genet Date: 2001-01-19 Impact factor: 11.025
Authors: David P Bernstein; Judith A Stein; Michael D Newcomb; Edward Walker; David Pogge; Taruna Ahluvalia; John Stokes; Leonard Handelsman; Martha Medrano; David Desmond; William Zule Journal: Child Abuse Negl Date: 2003-02
Authors: Cyrus P Zabetian; Sarah G Buxbaum; Robert C Elston; Michael D Köhnke; George M Anderson; Joel Gelernter; Joseph F Cubells Journal: Am J Hum Genet Date: 2003-04-30 Impact factor: 11.025
Authors: Charles F Gillespie; Bekh Bradley; Kristie Mercer; Alicia K Smith; Karen Conneely; Mark Gapen; Tamara Weiss; Ann C Schwartz; Joseph F Cubells; Kerry J Ressler Journal: Gen Hosp Psychiatry Date: 2009-06-09 Impact factor: 3.238
Authors: Barbara O Rothbaum; Megan C Kearns; Emily Reiser; Jennifer S Davis; Kimberly A Kerley; Alex O Rothbaum; Kristina B Mercer; Matthew Price; Debra Houry; Kerry J Ressler Journal: J Clin Psychiatry Date: 2014-12 Impact factor: 4.384